‘The Week in Health Law’ Podcast

By Nicolas Terry

twihl 14x14

How many podcasts discuss a Kardashian, drug pricing, and readmission penalties-all in the same episode? We welcome guest Aaron Kesselheim, from Harvard Medical School, and the Department of Health Policy and Management at Harvard’s T.H. Chan School of Public Health. Aaron is a prolific and insightful scholar whose work has influenced policy makers globally.

To start the packed show, Nic and Frank discussed a new study of ACOs, proposed budget cuts for AHRQ, worry over unintended consequences of readmission penalties, and EHR gag clauses (and developer codes of conduct). With Aaron’s help we discussed Kim Kardashian’s FDA feud over stealth marketing of an anti-nausea drug, the FDA guidance on limited character social media marketing, the nomination of the new FDA Commissioner, and how we could tackle high drug prices using Sovaldi as an example.

The Week in Health Law Podcast from Frank Pasquale and Nicolas Terry is a commuting-length discussion about some of the more thorny issues in Health Law & Policy.

Subscribe at iTunes, listen at Stitcher RadioTunein and Podbean, or search for The Week in Health Law in your favorite podcast app.

Show notes and more are at TWIHL.com. If you have comments, an idea for a show or a topic to discuss you can find us on twitter @nicolasterry @FrankPasquale @WeekInHealthLaw

Nicolas P. Terry

Nicolas Terry is the Hall Render Professor of Law at Indiana University McKinney School of Law where he serves as the Executive Director of the Hall Center for Law and Health and teaches various healthcare and health policy courses. His recent scholarship has dealt with health privacy, mobile health, the Internet of Things, Big Data, AI, and the opioid overdose epidemic. He serves on IU’s Grand Challenges Scientific Leadership Team, working on the addictions crisis and is the PI on addictions law and policy Grand Challenge grants. His podcast is at TWIHL.com, and he is @nicolasterry on Twitter.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.